Modulation of hemorheological parameters by the erythrocyte redox thiol status

Clinical Hemorheology and Microcirculation

Volumn 40, Issue 2, 2008, Pages 99-111

  Almeida, José Pedro ^a,b   Carvalho, Filomena Almeida ^a   Freitas, Teresa ^a   Saldanha, Carlota ^a  

^a UNIVERSITY OF LISBON   (Portugal)

^b Instituto de Bioquímica   (Portugal)

Author keywords

Dithiothreitol; Hemorheology; Red blood cell; Redox status

Indexed keywords

ACETYLCHOLINE; DITHIOTHREITOL; THIOL; VELNACRINE MALEATE;

ARTICLE; BLOOD RHEOLOGY; BLOOD SAMPLING; BLOOD SMEAR; CELL MEMBRANE FLUIDITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; HUMAN; HUMAN CELL; LIPID MEMBRANE; MALE; NORMAL HUMAN; OXIDATION REDUCTION REACTION; SHEAR STRESS; VENOUS BLOOD;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; CHOLINERGIC AGENTS; CHOLINESTERASE INHIBITORS; DITHIOTHREITOL; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTES; HEMATOLOGIC DISEASES; HUMANS; MALE; MEMBRANE FLUIDITY; MICROCIRCULATION; OXIDATION-REDUCTION; TACRINE;

EID: 57049093367     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: 10.3233/CH-2008-1120     Document Type: Article

References (43)

1. J.A. Dormandy, The clinical relevance of the flow properties of blood cells, Wien. Med. Wochenschr. 136 (1986), 41-43.
2. L. Dintenfass, Methods and instrumentation used in practice of clinical haemorheology, Biorheology 1 (1984), 63-69.
3. J.F. Stoltz, S. Muller, A. Kadi, V. Decot, P. Menu and D. Bensoussan, Introduction to endothelial cell biology, Clin. Hemorheol. Microcirc. 37 (2007), 5-8.
4. T. Gori, G. Di Stolfo, S. Sicuro, S. Dragoni, J.D. Parker and S. Forconi, The effect of ischemia and reperfusion on microvascular function: a human in vivo comparative study with conduit arteries, Clin. Hemorheol. Microcirc. 35 (2006), 169-173.
5. O.K. Baskurt and H.J. Meiselman, Blood rheology and hemodynamics, Semin. Thromb. Hemost. 29 (2003), 435-450.
6. H. Rieger, The role of hemorheology in the pathophysiology and treatment of arterial occlusive disease, Int. Angiol. 5 (1986), 161-167.
7. M. Delamaire and F. Durand, Erythrocyte aggregation and vascular pathology, J. Mal. Vasc. 15 (1990), 344-345 (in French).
8. M. Mantskava, N. Momtselidze, N. Pargalava and G. Mchedlishvili, Hemorheological disorders in patients with type 1 or 2 diabetes mellitus and foot gangrene, Clin. Hemorheol. Microcirc. 35 (2006), 307-310.
9. M.R. Boisseau, Roles of mechanical blood forces in vascular diseases, A clinical overview, Clin. Hemorheol. Microcirc. 33 (2005), 201-207. Review.
10. J.F. Stoltz, Red blood cell microrheology (clinical and pharmacological applications), Ric. Clin. Lab. 3 (1983), 53-70.
11. H. Schmid-Schönbein, Blood rheology and physiology of microcirculation, Ric. Clin. Lab. 1 (1981), 13-33.
12. H. Schmid-Schönbein, Microrheology of erythrocytes, blood viscosity, and the distribution of blood flow in the microcirculation, Int. Rev. Physiol. 9 (1976), 1-62.
13. R. Mesquita, I. Pires, C. Saldanha and J. Martins-Silva, Effects of acetylcholine and spermineNONOate on erythrocyte hemorheologic and oxygen carrying properties, Clin. Hemorheol. Microcirc. 25 (2001), 153-163.
14. T. Santos, R. Mesquita, J. Martins-Silva and C. Saldanha, Effects of choline on hemorheological properties and NO metabolism of human erythrocytes, Clin. Hemorheol. Microcirc. 29 (2003), 41-51.
15. F.A. Carvalho, A.V. Maria, J.M. Braz Nogueira, J. Guerra, J. Martins-Silva and C. Saldanha, The relation between the erythrocyte nitric oxide and hemorheological parameters, Clin. Hemorheol. Microcirc. 35 (2006), 341-347.
16. W.W. Cleland, Dithiothreitol, a new protective reagent for SH groups, Biochemistry 3 (1963), 480-482.
17. P. Di Simplicio, M.G. Cacace, L. Lusini, F. Giannerini, D. Giustarini and R. Rossi, Role of protein-SH groups in redox homeostasis - the erythrocyte as a model system, Arch. Biochem. Biophys. 355 (1998), 145-152.
18. M.C. Alliegro, Effects of dithiothreitol on protein activity unrelated to thiol-dissulfide exchange: For consideration in the analysis of protein function with Cleland's reagent, Anal. Biochem. 282 (2000), 102-106.
19. D.M. Rothwarf and H.A. Scheraga, Equilibrium and kinetic constants for the thiol-disulfide interchange reaction between glutathione and dithiothreitol, Proc. Natl. Acad. Sci. USA 89 (1992), 7944-7948.
20. L.B. Tee, A.R. Boobis, A.C. Huggett and D.S. Davies, Reversal of acetaminophen toxicity in isolated hamster hepatocytes by dithiothreitol, Toxicol. Appl. Pharmacol. 83 (1986), 294-314.
21. V.V. Lauriault and P.J. O'Brien, Molecular mechanism for prevention of N-acetyl-p-benzoquinoneimine cytotoxicity by the permeable thiol drugs diethyldithiocarbamate and dithiothreitol, Mol. Pharmacol. 40 (1991), 125-134.
22. H.T. Truong, J.E. Ferrell Jr and W.H. Huestis, Sulphydryl reducing agents and shape regulation in human erythrocytes, Blood 67 (1986), 214-221.
23. H.T. Truong, D.L. Daleke and W.H. Huestis, Dithiothreitol stimulates the activity of the plasma membrane aminophospholipid translocator, Biochim. Biophys. Acta. 1150 (1993), 57-62.
24. +)ATPase inhibition induced by zinc is reverted by dithiothreitol, Int. J. Biochem. Cell. Biol. 34 (2002), 516-524.
25. H.T. Truong, D.L. Daleke and W.H. Huestis, Human erythrocyte shape regulation: interaction of metabolic and redox status, Biochim. Biophys. Acta 1150 (1993), 51-56.
26. N.C. Santos, C. Saldanha and J. Martins-Silva, Gramicidin D and dithiothreitol effects on erythrocyte exovesiculation, Cell. Biochem. Biophys. 43 (2005), 419-430.
27. S.E. Moriarty-Craige and D.P. Jones, Extracellular thiols and thiol/disulfide redox in metabolism, Annu. Rev. Nutr. 24 (2004), 481-509.
28. N. Haugaard, Reflections on the role of the thiol group in biology, Ann. NY Acad. Sci. 899 (2000), 148-158.
29. H. Schmid-Sconbein, P. Ruef and O. Linderkamp, The shear stress diffractomer Rheodyn SSD for determination of erythrocyte deformability. I. Principle of operation and reproducibility, Clin. Hemorheol. 16 (1996), 48.
30. International Committee for Standardization in Haematology, Guidelines for measurement of blood viscosity and erythrocyte deformability. Expert panel on blood rheology, Clin. Hemorheol. 6 (1986), 439-453.
31. M. Rampling and G. Martin, A comparision of the myrenne erythrocyte aggregometer with older techniques for estimating erythrocyte aggregation, Clin. Hemorheol. 9 (1989), 41-46.
32. C. Saldanha, N.C. Santos and J. Martins-Silva, Fluorescent probes DPH, TMA-DPH and C17-HC induce erythrocyte exovesiculation, J. Membr. Biol. 190 (2002), 75-82.
33. Z.J. Huang and R.P. Haugland, Partition coefficients of fluorescent probes with phospholipid membranes, Biochem. Biophys. Res. Commun. 181 (1991), 166-171.
34. G. Schiliro, S. Livalti, E. Geremia, L. Masoti, A. Vanella and L. Mollica, Fluorescence studies on erythrocyte membranes from normal and thalassemic subjects, IRCS Med. Sci. 9 (1981), 599.
35. G. Mchedlishvili, Disturbed blood flow structuring as critical factor of hemorheological disorders in microcirculation, Clin. Hemorheol. Microcirc. 19 (1998), 315-325.
36. G. Lowe, A. Rumley, J. Norrie, I. Ford, J. Shepherd, S. Cobbe, P. Macfarlane and C. Packard, Blood rheology, cardio vascular risk factors, and cardiovascular disease: the west of Scotland coronary prevention study, Thromb. Haemost. 84 (2000), 553-558.
37. J. Freitas, J. Braz-Nogueira, J. Nogueira da Costa and J. Martins-Silva, Whole blood filterability and blood oxygen transport in human hypertension, Clin. Hemorheol. 3 (1983), 367-373.
38. K. Shiraishi, S. Matsuzaki, H. Ishida and H. Nakazawa, Impaired erythrocyte deformability and membrane fluidity in alcoholic liver disease: participation in disturbed hepatic microcirculation, Alcohol, Suppl. 1A (1993), 59-64.
39. X.Q. Shan, T.Y. Aw and D.P. Jones, Glutathione-dependent protection against oxidative injury, Pharmacol. Ther. 47 (1990), 61-71.
40. W. Dröge, Aging-related changes in the thiol/disulfide redox state: implications for the use of thiol antioxidants, Exp. Gerontol. 37 (2002), 1333-1345.
41. L. El-Khairy, P.M. Ueland, H. Refsum, I.M. Graham and S.E. Vollset, Plasma total cysteine as a risk factor for vascular disease: The European Concerted Action Project, Circulation 103 (2001), 2544-2549.
42. M. Julius, C.A. Lang, L. Gleiberman, E. Harburg, W. DiFranceisco and A. Schork, Glutathione and morbidity in a community-based sample of elderly, J. Clin. Epidemiol. 47 (1994), 1021-1026.
43. C. Bayle, E. Caussé and F. Couderc, Determination of aminothiols in body fluids, cells, and tissues by capillary electrophoresis, Electrophoresis 25 (2004), 1457-1472.